Skip to main content

Merck & Co., Inc. Lagevrio revenue

  • MRK · NYSE
  • Pharmaceuticals
  • S&P 500
$147.76+0.55%Close 13 Nov 2026 · Market value $361.6B

Lagevrio revenue at Merck & Co., Inc. came to $17.0M for the quarter to 30 Sep 2026, down 87.7% from a year earlier.

As Merck & Co., Inc. reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$192.0MDec 2023$350.0MMar 2024$110.0MJun 2024$383.0MSep 2024$121.0MDec 2024$102.0MMar 2025$83.0MJun 2025$138.0MSep 2025$57.0MDec 2025$28.0MMar 2026$5.0MJun 2026$17.0MSep 2026
Merck & Co., Inc. Lagevrio revenue, every reported period
Period endingLagevrio revenueChange on a yearFiled
30 Sep 2026$17.0Mdown 87.7%4 Nov 2026
30 Jun 2026$5.0Mdown 94.0%7 Aug 2026
31 Mar 2026$28.0Mdown 72.5%4 May 2026
31 Dec 2025$57.0Mdown 52.9%24 Feb 2026
30 Sep 2025$138.0Mdown 64.0%5 Nov 2025
30 Jun 2025$83.0Mdown 24.5%5 Aug 2025
31 Mar 2025$102.0Mdown 70.9%2 May 2025
31 Dec 2024$121.0Mdown 37.0%25 Feb 2025
30 Sep 2024$383.0Mdown 40.2%6 Nov 2024
30 Jun 2024$110.0Mdown 45.8%5 Aug 2024
31 Mar 2024$350.0Mdown 10.7%3 May 2024
31 Dec 2023$192.0Mdown 76.7%26 Feb 2024
30 Sep 2023$640.0Mup 46.8%3 Nov 2023
30 Jun 2023$203.0Mdown 82.8%7 Aug 2023
31 Mar 2023$392.0Mdown 87.9%5 May 2023
31 Dec 2022$825.0Mdown 13.3%24 Feb 2023
30 Sep 2022$436.0M—3 Nov 2022
30 Jun 2022$1.2B—5 Aug 2022
31 Mar 2022$3.2B—5 May 2022
31 Dec 2021$952.0M—25 Feb 2022
30 Sep 2021$0—5 Nov 2021
30 Jun 2021$0—9 Aug 2021
31 Mar 2021$0—5 May 2021

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Merck & Co., Inc.: Keytruda revenue · Gardasil/Gardasil 9 revenue · Livestock revenue · Keytruda Qlex revenue · ProQuad/M-M-R II/Varivax revenue · Winrevair revenue · Companion Animal revenue · Lynparza alliance revenue · Prevymis revenue · Welireg revenue · Lenvima alliance revenue · Capvaxive revenue · RotaTeq revenue · Vaxneuvance revenue · Janumet revenue · Januvia revenue · Ohtuvayre revenue · Reblozyl alliance revenue · Bridion revenue · Adempas/Verquvo alliance revenue · Zerbaxa revenue · Adempas revenue · Delstrigo revenue · Isentress/Isentress HD revenue · financial statements

Every KPI and segment of MRK, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.